These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8888112

  • 1. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides.
    Forloni G, Tagliavini F, Bugiani O, Salmona M.
    Prog Neurobiol; 1996 Jul; 49(4):287-315. PubMed ID: 8888112
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N, Gu Y, Bose S, Kalepu S, Mishra RS, Verghese S.
    Front Biosci; 2002 Apr 01; 7():a60-71. PubMed ID: 11897566
    [Abstract] [Full Text] [Related]

  • 4. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T, Lins L, Goethals M, Vanloo B, Baert J, Vandekerckhove J, Rosseneu M, Brasseur R.
    J Mol Biol; 1997 Dec 05; 274(3):381-93. PubMed ID: 9405147
    [Abstract] [Full Text] [Related]

  • 5. On the biology of prions.
    Prusiner SB, Gabizon R, McKinley MP.
    Acta Neuropathol; 1987 Dec 05; 72(4):299-314. PubMed ID: 3554880
    [Abstract] [Full Text] [Related]

  • 6. [Amyloidgenesis in prion disease].
    Tsuboi Y.
    Brain Nerve; 2014 Jul 05; 66(7):849-55. PubMed ID: 24998829
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
    Agostinho P, Lopes JP, Velez Z, Oliveira CR.
    Neurochem Int; 2008 May 05; 52(6):1226-33. PubMed ID: 18295934
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
    Soto C, Kascsak RJ, Saborío GP, Aucouturier P, Wisniewski T, Prelli F, Kascsak R, Mendez E, Harris DA, Ironside J, Tagliavini F, Carp RI, Frangione B.
    Lancet; 2000 Jan 15; 355(9199):192-7. PubMed ID: 10675119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
    Taylor DR, Hooper NM.
    Semin Cell Dev Biol; 2007 Oct 15; 18(5):638-48. PubMed ID: 17822928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
    Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M.
    Neurodegener Dis; 2008 Oct 15; 5(6):347-54. PubMed ID: 18349519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.